Utah Medical Products, Inc. (UTMD)
74.80
+0.31
(+0.42%)
USD |
NASDAQ |
Sep 29, 16:00
74.80
0.00 (0.00%)
After-Hours: 18:12
Utah Medical Products Market Cap : 238.09M for Sept. 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 28, 2026 | 237.10M |
| September 25, 2026 | 236.11M |
| September 24, 2026 | 237.93M |
| September 23, 2026 | 238.76M |
| September 22, 2026 | 244.01M |
| September 21, 2026 | 237.07M |
| September 18, 2026 | 235.41M |
| September 17, 2026 | 236.15M |
| September 16, 2026 | 235.73M |
| September 15, 2026 | 237.55M |
| September 14, 2026 | 224.94M |
| September 11, 2026 | 221.89M |
| September 10, 2026 | 221.66M |
| September 09, 2026 | 221.92M |
| September 08, 2026 | 220.14M |
| September 04, 2026 | 226.31M |
| September 03, 2026 | 225.07M |
| September 02, 2026 | 228.03M |
| September 01, 2026 | 228.41M |
| August 31, 2026 | 226.41M |
| August 28, 2026 | 231.63M |
| August 27, 2026 | 228.54M |
| August 26, 2026 | 225.64M |
| August 25, 2026 | 225.87M |
| August 24, 2026 | 227.97M |
| Date | Value |
|---|---|
| August 21, 2026 | 227.74M |
| August 20, 2026 | 227.33M |
| August 19, 2026 | 229.56M |
| August 18, 2026 | 229.18M |
| August 17, 2026 | 223.48M |
| August 14, 2026 | 225.99M |
| August 13, 2026 | 229.49M |
| August 12, 2026 | 229.59M |
| August 11, 2026 | 228.98M |
| August 10, 2026 | 227.04M |
| August 07, 2026 | 225.45M |
| August 06, 2026 | 222.71M |
| August 05, 2026 | 226.66M |
| August 04, 2026 | 230.13M |
| August 03, 2026 | 231.56M |
| July 31, 2026 | 224.47M |
| July 30, 2026 | 221.44M |
| July 29, 2026 | 225.80M |
| July 28, 2026 | 225.87M |
| July 27, 2026 | 219.95M |
| July 24, 2026 | 213.71M |
| July 23, 2026 | 204.28M |
| July 22, 2026 | 220.23M |
| July 21, 2026 | 220.10M |
| July 20, 2026 | 220.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 175.11B |
| AngioDynamics, Inc. | 649.28M |
| Alphatec Holdings, Inc. | 1.583B |
| AtriCure, Inc. | 2.953B |
| Baxter International, Inc. | 12.15B |
Market Cap Related Metrics
| PE Ratio | 22.78 |
| PS Ratio | 6.616 |
| Price to Book Value | 1.951 |
| Price to Free Cash Flow | 20.87 |
| Price | 74.80 |
| Earnings Yield | 4.39% |
| Operating PE Ratio | 22.83 |
| Normalized PE Ratio | 22.49 |